Table 1.

Change of blood pressure profile after 24 weeks consumption.

		Group 1 Placebo (n = 24, M14/F10)		Group 2 Policosanol 10 mg (n = 29, M21/F8)		Group 3 Policosanol 20 mg (n = 31, M22/F9)
Age		32 ± 14		34 ± 16		31 ± 12
Body composition		Week 0	Week 24	Week 0	Week 24	Week 0	Week 24
BMI		22.3 ± 1.5	22.5 ± 1.4	23.2 ± 1.8	23.4 ± 1.8	23.7 ± 1.5	23.8 ± 1.3
Subcutaneous fat (kg)		12.3 ± 2.3	12.4 ± 2.1	13.6 ± 2.5	14.1 ± 2.7	13.8 ± 2.5	14.4 ± 1.8
Visceral fat (kg)		1.7 ± 0.5	1.6 ± 0.4	2.0 ± 0.5	2.1 ± 0.6	2.0 ± 0.5	2.1 ± 0.4
Peripheral BP (mmHg)		Week 0	Week 24	Week 0	Week 24	Week 0	Week 24
SphygmoCor	Systolic	135 ± 12	132 ± 11	139 ± 16	130 ± 15**	136 ± 8	123 ± 11***
	Diastolic	88 ± 8	84 ± 8	89 ± 10	87 ± 11	87 ± 7	81 ± 9*
Omron	Systolic	134 ± 12	135 ± 10	140 ± 18	134 ± 20*	138 ± 11	122 ± 10***
	Diastolic	84 ± 9	83 ± 9	85 ± 12	84 ± 15	82 ± 10	72 ± 10**
Mercury	Systolic	131 ± 6	129 ± 8	134 ± 12	130 ± 17*	135 ± 6	121 ± 9***
	Diastolic	83 ± 5	81 ± 8	84 ± 10	82 ± 10	84 ± 5	75 ± 9*
Average	Systolic	138 ± 9	132 ± 6	135 ± 13	128 ± 6**	138 ± 12	126 ± 13***
	Diastolic	87 ± 6	83 ± 6	86 ± 10	83 ± 12	87 ± 7	79 ± 8**
Aortic BP (mmHg)		Week 0	Week 24	Week 0	Week 24	Week 0	Week 24
Aortic	Systolic	123 ± 12	117 ± 9	130 ± 14	120 ± 13*	123 ± 13	113 ± 12***
	Diastolic	90 ± 8	85 ± 7	92 ± 10	86 ± 8*	91 ± 7	84 ± 5**
Mean arterial pressure		104 ± 9	100 ± 8	104 ± 11	97 ± 11*	103 ± 7	93 ± 9**
Pulse pressure		32 ± 8	32 ± 4	35 ± 10	30 ± 5	32 ± 5	29 ± 5

Data are expressed as mean±SD.

^***p < 0.001 vs. week 0;

^**p < 0.01 vs. week 0;

^*p < 0.05 vs. week 0 in each group. AU, arbitrary unit; BP, blood pressure; BMI, body mass index.